Skip to content

Virtual Reality for Pain Management in Burn Patients

Virtual Reality for Pain Management in Burn Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04685486
Enrollment
50
Registered
2020-12-28
Start date
2018-06-01
Completion date
2027-05-01
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Virtual Reality, Pain Management, Anxiety, Depression

Brief summary

This study is a randomized proof-of-concept study to assess the efficacy of Virtual Reality (VR) vs standard of care in 50 adult patients in the New York Presbyterian Burn Unit. The participants who are randomized to receive the virtual reality intervention will also receive opioids, which is the standard of care and is known to be effective. Participants will be randomly assigned to two groups. The first group will receive VR during their painful procedure (e.g., wound dressing changes, physical therapy etc.) in addition to the standard of care. The other group will receive standard of care (and no VR).

Interventions

OTHERVirtual Reality

Immersive and interactive game played through a portable head-mounted display as a distraction mechanism

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 8 years and older * Patients with a burn injury and is in the Burn Unit at New York Presbyterian * Awake, alert, ambulatory * The burn comprises less than 15% total body surface area (TBSA) * The patient does not require conscious sedation such as ketamine for staple removal or wound dressing changes * The patient is able to give informed consent

Exclusion criteria

* Diagnosis of a cognitive disorder, psychotic disorder or bipolar I as determined by self-report from previous diagnosis * Current opioid abuse

Design outcomes

Primary

MeasureTime frameDescription
Change in PainPeri-procedural: 30 minutes before to two hours after the painful event.Initial determination of the clinical efficacy of VR in reducing the total pain (determined by the subjective standard 0-10 pain scale) where 0 = no pain and 10 = worst pain.
Change in narcotic dosePeri-procedural: 30 minutes before to two hours after the painful event.Dose of narcotics needed peri-procedure

Secondary

MeasureTime frameDescription
Change in narcotic doseDay 1 of hospitalization to last day of hospitalization (approximately 15 days)Determine if the one-time VR-distraction intervention reduces dose of analgesics for the day after the painful events and the remained of the post-procedure hospitalization
Change in anxiolytics doseDay 1 of hospitalization to last day of hospitalization (approximately 15 days)Determine if the one-time VR-distraction intervention reduces anxiolytic dose after painful event
Change in Anxiety SymptomsPeri-procedural: 30 minutes before to two hours after the painful event.Determined by visual analog scales (0-100) where 0 = no anxiety and 100 = worst possible anxiety.
Change in Depressive SymptomsPeri-procedural: 30 minutes before to two hours after the painful event.Determined by visual analog scales (0-100) where 0 = no depression and 100 = worst possible depression.

Countries

United States

Contacts

CONTACTOlivia Baryluk, BS
olb4002@med.cornell.edu212-821-0783
PRINCIPAL_INVESTIGATORJoAnn Difede, PhD

Weill Medical College of Cornell University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026